ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Protara Therapeutics Inc

Protara Therapeutics Inc (TARA)

4,54
0,01
(0,22%)
Geschlossen 27 März 9:00PM
4,54
0,00
( 0,00% )
Vor Marktöffnung: 9:30AM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
4,54
Gebot
4,00
Fragen
4,54
Volumen
2
0,00 Tagesbereich 0,00
1,595 52-Wochen-Bereich 10,25
Marktkapitalisierung
Handelsende
4,54
Handelsbeginn
-
Letzte Trade
2
@
4.53
Letzter Handelszeitpunkt
10:13:35
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
288.443
Ausgegebene Aktien
36.767.465
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,69
Gewinn pro Aktie (EPS)
-1,21
Erlöse
-
Nettogewinn
-44,6M

Über Protara Therapeutics Inc

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatmen... Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD). Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Protara Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TARA. The last closing price for Protara Therapeutics was US$4,54. Over the last year, Protara Therapeutics shares have traded in a share price range of US$ 1,595 to US$ 10,25.

Protara Therapeutics currently has 36.767.465 shares in issue. The market capitalisation of Protara Therapeutics is US$166,92 million. Protara Therapeutics has a price to earnings ratio (PE ratio) of -0.69.

TARA Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1004.544.81424.382819584.61605937CS
41.1433.52941176473.44.81423.222235064.18444587CS
12-1.12-19.78798586575.666.1833.222884434.5277544CS
262.46118.2692307692.0810.251.59512906635.626729CS
520.5513.78446115293.9910.251.5957743875.1204112CS
156-1.12-19.78798586575.6610.251.042828994.92024394CS
260-16.94-78.864059590321.4867.0791.042132026.47616309CS

TARA - Frequently Asked Questions (FAQ)

What is the current Protara Therapeutics share price?
The current share price of Protara Therapeutics is US$ 4,54
How many Protara Therapeutics shares are in issue?
Protara Therapeutics has 36.767.465 shares in issue
What is the market cap of Protara Therapeutics?
The market capitalisation of Protara Therapeutics is USD 166,92M
What is the 1 year trading range for Protara Therapeutics share price?
Protara Therapeutics has traded in the range of US$ 1,595 to US$ 10,25 during the past year
What is the PE ratio of Protara Therapeutics?
The price to earnings ratio of Protara Therapeutics is -0,69
What is the reporting currency for Protara Therapeutics?
Protara Therapeutics reports financial results in USD
What is the latest annual profit for Protara Therapeutics?
The latest annual profit of Protara Therapeutics is USD -44,6M
What is the registered address of Protara Therapeutics?
The registered address for Protara Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Protara Therapeutics website address?
The website address for Protara Therapeutics is protaratx.com
Which industry sector does Protara Therapeutics operate in?
Protara Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PRTGPortage Biotech Inc
US$ 9,50
(101,70%)
1,28M
DBVTDBV Technologies SA
US$ 6,07
(55,24%)
2,23M
NTRPNextTrip Inc
US$ 7,99
(40,92%)
1
TWGTop Wealth Group Holding Ltd
US$ 0,2529
(38,35%)
24,25M
LCFYLocafy Ltd
US$ 7,00
(31,93%)
4
BTBDBT Brands Inc
US$ 0,52
(-59,06%)
74
DRCTDirect Digital Holdings Inc
US$ 0,82
(-38,35%)
166,14k
TBNKTerritorial Bancorp Inc
US$ 5,31
(-37,89%)
4
AUDCAudioCodes Ltd
US$ 6,31
(-35,61%)
18
XTIAXTI Aerospace Inc
US$ 1,72
(-30,08%)
37,58k
TWGTop Wealth Group Holding Ltd
US$ 0,2529
(38,35%)
24,25M
STSSSharps Technology Inc
US$ 0,1641
(7,47%)
12,56M
RNAZTransCode Therapeutics Inc
US$ 0,6343
(21,98%)
7,24M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10,95
(3,11%)
6,75M
LGMKLogicMark Inc
US$ 0,0413
(-19,02%)
5,23M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen